<?xml version='1.0' encoding='utf-8'?>
<document xmlns="https://code.dccouncil.us/schemas/dc-library" xmlns:codified="https://code.dccouncil.us/schemas/codified" xmlns:codify="https://code.dccouncil.us/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude" id="D.C. Law 9-252">
  <num type="law">9-252</num>
  <heading type="short">DRUG PARAPHERNAILIA ACT OF 1982 PREVENTION OF TRANSMISSION OF THE HUMAN IMMUNODEFICIENCY VIRUS AMENDMENT ACT OF 1992, BILL 9-542</heading>
  <meta>
    <effective>1993-03-25</effective>
    <citations>
      <citation type="law" url="./docs/9-252.pdf">D.C. Law 9-252</citation>
      <citation type="register">40 DCR 787</citation>
    </citations>
    <history url="http://lims.dccouncil.us/Legislation/B9-0542">
      <narrative>Law 9-252 was introduced in Council and assigned Bill No. 9-542, which was referred to the Committee on the Judiciary. The Bill was adopted on first and second readings on December 1, 1992, and December 15, 1992, respectively. Signed by the Mayor on January 14, 1993, it was assigned Act No. 9-398 and transmitted to both Houses of Congress for its review. D.C. Law 9-252 became effective on March 25, 1993.</narrative>
    </history>
    <search-text>ENROLLMENT(S) kwiktag ® 103 248 850 COUNCIL OF THE DISTRICT OF COLUMBIA NOTICE D.C. LAW 9-252 "Prevention of Transmission of the Human Immunodeficiency Virus Amendment Act of 1992 Pursuant to Section 412 of the District of Columbia Self- Government and Governmental Reorganization Act, P. L. 93-198 the Act the Council of the District of Columbia adopted Bill No. 9-542 on first and second readings, December 1, 1992, and December 15, 1992, respectively. Following the signature of the Mayor on January 14, 1993, this legislation was assigned Act No. 9-398, published in the January 29, 1993, edition of the D.C. Register Vol. 40 page 787) and transmitted to Congress on January 26, 1993 for a 30-day review, in accordance with Section 602(c)(1) of the Act. The Council of the District of Columbia hereby gives notice that the 30-day Congressional Review Period has expired, and therefore, cites this enactment as D.C. Law 9-252, effective March 25, 1993 C c_~qR o’t"the Council Dates Counted Durinq the 30-_d~a essional Review Period: January 26,27 February 2,3,4,16,17,18,19,22,23,24,25,26 ~arch 1,2,3,4,5,8,9,10,11,12,15,16,17,18,23,24 Enrolled Original AN ACT D,C. ACT 9-398 Coditlcation District of Columbia Code Suppiernent) IN THE COUNCIL OF THE DISTRICT OF COLUMBIA JANUARY 14, 1993 To amend the Drug Paraphernalia Act of 1982 to provide an exemption for hypodermic syringes and needles which are distributed by the Commission of Public Health as part of a defined needle exchange program. BE IT ENACTED BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this act may be cited as the "Prevention of Transmission of the Human Immunodeficiency Virus Amendment Act of 1992 Sec. 2. The Drug Paraphernalia Act of 1982, effective September New Section 17, 1982 (D.C. Law 4-149; D.C. Code § 33-601 et seq is amended by 33-603.1 adding a new section 4a to read as follows Sec. 4a a) The Mayor is authorized to establish within the Department of Human Services a Needle Exchange Program Program which may provide clean hypodermic needles and syringes to intravenous substance abusers who have been admitted into or are awaiting admission into a program of treatment for substance abuse addiction and who have been provided with a medical examination, counseling on substance abuse addiction and counseling and information on the Human Immunodeficiency Virus HIV b) The Program authorized by subsection (a) of this section shall be operated by the Commission of Public Health in the Department of Human Services. Only qualified medical officers, registered nurses, and counselors specifically designated by the Commissioner of Public Health shall be authorized to distribute hypodermic needles and syringes in the Program c) The Commissioner of Public Health shall provide all persons participating in the Program authorized by subsection (a) of this section with a written statement of the person’s participation in the program, signed by the Commissioner of Public Health, or the Commissioner’s designee. No person participating in the Program shall be required to carry such a statement d) Notwithstanding the provisions of section 4 of this act or section 410 of the District of Columbia Uniformed Controlled Substances Act of 1981, effective August 5, 1981 (D.C. Law 4-29; D.C. Code § 33-550 it shall not be unlawful for any person who is participating in the Program authorized by subsection (a) of this section to possess, or for any person authorized by subsection (b) of this section, to deliver any hypodermic syringe or needle distributed as part of the Program. Enrolled Original e) Neither the District of Columbia nor its officers or employees shall be liable for any injury or damage resulting from use of or contact with any needle distributed as part of the Program authorized by subsection (a) of this section f) All needles and syringes distributed by the Commission of Public Health as part of the Program shall be made identifiable through the use of permanent markings, or coloring coding, or any other method determined by the Commissioner to be effective in identifying the needles and syringes g) The Mayor shall issue an annual evaluation report on the Program. The report shall address the following components 1) Number of Program participants served daily 2) Demographics of Program participants, including age, sex, ethnicity, address or neighborhood of residence, education, and occupation 3) Impact of Program on behaviors which put the individual at risk for HIV transmission 4) Number of materials distributed, including needles, bleach kits, alcohol swabs, and educational materials 5) Impact of Program on incidence of HIV infection in the District. In determining this, the Mayor shall take into account the following factors A) Estimates of the HIV infection rate in the District at start of Program as compared to the rate at the end of the Program year B) Estimates of the ttIV infection rate among intravenous drug users in the District at start of Program as compared to the rate at the end of the Program year C) Number of HIV-positive mothers giving birth in the District at the start of the Program as compared to the number at the end of the Program year D) Estimates of the HIV infection rate among newborns at start of Program in the District as compared to the rate at the end of the Program year; and 6) Costs of the Program versus direct and indirect costs of HIV infection and Acquired Immunodeficiency Syndrome AIDS in the District h) Data on Program participants shall be obtained through pre- or post-admittance interviews. The interviews shall be used to obtain the following information 1) Reasons for participating in Program 2) Drug use history, including type of drug used, frequency of use, method of ingestion, length of time drugs used, and frequency of needle sharing 3) Sexual behavior and history, including the participant’s self-described sexual identity, number of sexual partners in the past 30 days or 6 months, number of sexual partners who were also intravenous drug users, frequency of condom use, and number of times sex was used in exchange for money or drugs 4) Health assessment, including whether the participant has been tested for HIV infection and whether the results were negative or positive; and Enrolled Original 5) Impact of Program on the participant’s behavior and attitudes, including any increase or decrease in drug use or needle sharing, changes in high-risk sexual behaviors, or willingness to follow through with drug treatments i) The Mayor shall explore the feasibility of establishing a system to test used needles and syringes received by the Commission of Public Health for HIV antibody contamination. The Mayor shall prepare a feasibility report on needle and syringe testing and shall submit this report to the Council for review no later than 120 days after the enactment of the Prevention of Transmission of the Human Immunodeficiency Virus Emergency Amendment Act of 1992, effective June 30, 1992 (D.C. Act 9-235; 39 DCR 5296 If the report finds that needles and syringe testing would be beneficial and feasible to implement, such a system shall be incorporated into the program Sec. 3. This act shall take effect after a 30-day period of Congressional review following approval by the Mayor (or in the event of veto by the Mayor, action by the Council of the District of Columbia to override the veto) as provided in section 602(c)(1) of the District of Columbia Self-Government and Governmental Reorganization Act, approved December 24, 1973 (87 Stat. 813; D.C. Code § 1-233(c)(1 and publication in either the District of Columbia Register, the District of Columbia Statutes-at-Large, or the District of Columbia Municipal Regulations. C un~ l~ t ~s ict o Columbia District of Columbia APPROVED: January 14, 1993 @ COUNCIL OF THE DISTRICT OF COLUMBIACouncil Period Nine RECORD OF OFFICIAL COUNCIL VOTE DOCKET NO: Bill [] Item on Consent Calendar I~ ACTION &amp;amp; DATE VOICE VOTE: 9-542 Adopted First Readinq, 12-1-92 Approved Recorded vote on request Absent: Cropp, Jarvis and Thomas COUNCIL MEMBER C~NMN. WILSON BRAZIL CRAWFORD CROPp EVANS [] ROLL CALL VOTE RESULT AYE NAY NV. A.B. X Indicajes Vote v"~tecretar t~he Council [~ Item or~ Consent Calendar ACTION &amp;amp; DATE [ VOICE VOTE: Recorded vote on request COUNCIL MEMBER AYE NAY N.V. A.B. COUNCIL MEMBER JARV I S ROLA~ LIGHTFOOT SMITH, JR SON THOMAS, SR. NATHANSON RAY A.B Absent CERTIFICATION RECORD N.V Present, not voting Date Adopted Final Approved Reading, 12-15-92 AYE NAY Absent: all present [] ROLL CALL VOTE RESULT COUNCIL MEMBER AYE NAY N.V, A.B, CK~N. WILSON BRAZIL CRAWFORD CROPP EVANS X Indicates Vote Secr#ryto the Council Ite~n on Consent Calendar COUNCILMEMBER AYE NAY N.V.A.B COUNCIL MEMBER AYE NAY N.V. N.V Present, not voting JARVI$ LIGHTFOOT MASON NATHANSON RAY A.B Absent CERTIFICATION RECORD ROLARK SMITH. JR. THOMAS, SR. Date [] ACTION &amp;amp; DATE: [] VOICE VOTE: Recorded vote on request Absent: [] ROLL CALL VOTE RESULT COUNCIL MEMBER AYE NAY N.V. A.B CIIMN. WILSON BRAZIL CRAWFORD ~ROPP EVANS X Indicates Vote COUNCIL MEMBER JARV I S LIGHTFOOT MASON NATHANSON RAY A.B Absent AYE NAY N.V. A.B. N.V Present, not voting CERTIFICATION RECORD COUNCIL MEMBER ROLARK SMITH, JR, THOMAS. SR NV Secretary to the Council Date</search-text>
  </meta>
</document>
